NITISINONE — all Canadian products
12 DINs
8 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is NITISINONE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02457725 | MDK-NITISINONE | MENDELIKABS INC | Capsule | Oral | NITISINONE 5 MG | Marketed | |
| 02457717 | MDK-NITISINONE | MENDELIKABS INC | Capsule | Oral | NITISINONE 2 MG | Marketed | |
| 02457733 | MDK-NITISINONE | MENDELIKABS INC | Capsule | Oral | NITISINONE 10 MG | Marketed | |
| 02459728 | ORFADIN | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | Capsule | Oral | NITISINONE 10 MG | Marketed | |
| 02459736 | ORFADIN | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | Capsule | Oral | NITISINONE 20 MG | Marketed | |
| 02459698 | ORFADIN | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | Capsule | Oral | NITISINONE 2 MG | Marketed | |
| 02459701 | ORFADIN | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | Capsule | Oral | NITISINONE 5 MG | Marketed | |
| 02469693 | ORFADIN | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | Suspension | Oral | NITISINONE 4 MG | Marketed | |
| 02470055 | MDK-NITISINONE | MENDELIKABS INC | Capsule | Oral | NITISINONE 20 MG | Dormant | |
| 02458624 | NITISINONE TABLETS | CYCLE PHARMACEUTICALS LTD. | Tablet | Oral | NITISINONE 5 MG | Cancelled Post Market | |
| 02458632 | NITISINONE TABLETS | CYCLE PHARMACEUTICALS LTD. | Tablet | Oral | NITISINONE 10 MG | Cancelled Post Market | |
| 02458616 | NITISINONE TABLETS | CYCLE PHARMACEUTICALS LTD. | Tablet | Oral | NITISINONE 2 MG | Cancelled Post Market |
Browse other molecules: